Products NextBio Enterprise

NextBio Enterprise provides pharmaceutical and biotechnology companies, commercial and non-profit R&D organizations, and academic institutions a completely integrated solution that enables a dramatic increase in research productivity, better leverage of investment in past experiments, and improved collaboration across therapeutic groups and geographic boundaries. NextBio Enterprise allows companies to unlock the value of internal research by integrating publicly available experimental data processed by the NextBio scientific team with proprietary experimental data. NextBio Enterprise breaks down silos within R&D organizations and creates synergies, as internal proprietary data and publicly available experiments are analyzed together in an integrated search and discovery environment.

Features

NextBio Enterprise provides organizations a number of unique features including:

• Access to a curated and correlated repository of experimental data from an extensive set of public sources, covering a broad range of techniques and therapeutic areas
• Advanced search and discovery capabilities
• Automated and secure upload of internally generated experimental data and correlation with publicly available data
• Extensive tissue, disease, and compound ontologies to ensure accurate correlations
• An intuitive, web-based interface resulting in quick adoption
• Collaboration capabilities streamlining communication and information sharing
• State-of-the-art security and data protection
• Extensive set of out-of-the-box integrations and APIs
• SaaS (Software as a Service) delivery model requiring minimal or no IT support

Benefits

NextBio Enterprise allows organizations to:

• Effectively exploit publicly available and proprietary data accelerating new scientific discoveries
• Maximize Return on Investment (ROI) for each research project by extracting greater knowledge from new and past experiments
• Make new discoveries and enhance product pipelines by interpreting data in the broadest possible scientific context
• Reduce the number of redundant experiments and improve the quality and design of future experiments
• Dramatically increase collaboration and knowledge sharing across therapeutic and geographic groups within your organization

NextBio Enterprise — Supporting the Research Value Chain

NextBio Enterprise is designed to support a multitude of key roles within the research value chain:

Research Scientists (biologists, chemists, toxicologists) — NextBio Enterprise allows researchers to validate or generate novel hypotheses prior to investing in new experiments. Researchers can correlate results from high-throughput and high-content screening assays to better understand compounds of interest. Researchers can also validate biomarker activity and identify new targets.

Clinical Scientists — NextBio Enterprise allows the clinical scientist to mine the aggregate experimental and clinical data within NextBio to facilitate translational research efforts and elucidate alternative indications for existing compounds.

Program Directors — NextBio Enterprise allows program directors to assemble their team's collective knowledge and find connections between data from diverse therapeutic areas to drive program success.

Bioinformaticians — NextBio Enterprise allows bioinformaticians to explore experimental results and correlate these to a wealth of public and private data within NextBio to assist scientists with the interpretation of their studies.